CA 07190/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1981	1
1982	1
1989	1
1990	1
1993	2
1994	2
1997	1
1998	2
1999	1
2002	1
2024	0

1

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma.

Schoenfeld DA, Rosenbaum C, Horton J, Wolter JM, Falkson G, DeConti RC. Schoenfeld DA, et al. Cancer. 1982 Dec 15;50(12):2757-62. doi: 10.1002/1097-0142(19821215)50:12<2757::aid-cncr2820501211>3.0.co;2-j. Cancer. 1982. PMID: 7139566

2

Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.

Hillner BE, Kirkwood JM, Atkins MB, Johnson ER, Smith TJ. Hillner BE, et al. J Clin Oncol. 1997 Jun;15(6):2351-8. doi: 10.1200/JCO.1997.15.6.2351. J Clin Oncol. 1997. PMID: 9196150

3

Morphology and other prognostic factors of hepatocellular carcinoma.

Chedid A, Ryan LM, Dayal Y, Wolf BC, Falkson G. Chedid A, et al. Arch Pathol Lab Med. 1999 Jun;123(6):524-8. doi: 10.5858/1999-123-0524-MAOPFO. Arch Pathol Lab Med. 1999. PMID: 10383806 Free article.

4

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study.

Falkson CI, Ibrahim J, Kirkwood JM, Coates AS, Atkins MB, Blum RH. Falkson CI, et al. J Clin Oncol. 1998 May;16(5):1743-51. doi: 10.1200/JCO.1998.16.5.1743. J Clin Oncol. 1998. PMID: 9586887 Clinical Trial.

5

Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.

Bell DW, Erban J, Sgroi DC, Haber DA. Bell DW, et al. Cancer Res. 2002 May 15;62(10):2741-3. Cancer Res. 2002. PMID: 12019146

6

Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans.

Tilg H, Trehu E, Shapiro L, Pape D, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Cytokine. 1994 Mar;6(2):215-9. doi: 10.1016/1043-4666(94)90044-2. Cytokine. 1994. PMID: 8032003 Clinical Trial.

7

Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine.

Stolbach LL, Begg CB, Hall T, Horton J. Stolbach LL, et al. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):689-92. Cancer Treat Rep. 1981. PMID: 6454485 Clinical Trial.

8

Phase II trial of carboplatin in soft-tissue sarcoma.

Goldstein D, Cheuvart B, Trump DL, Shiraki M, Comis RL, Tormey DC, Harris JE, Borden EC. Goldstein D, et al. Am J Clin Oncol. 1990 Oct;13(5):420-3. doi: 10.1097/00000421-199010000-00011. Am J Clin Oncol. 1990. PMID: 2220662 Clinical Trial.

9

A method for the detection of erythrocyte-bound interleukin-8 in humans during interleukin-1 immunotherapy.

Tilg H, Pape D, Trehu E, Shapiro L, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. J Immunol Methods. 1993 Aug 9;163(2):253-8. doi: 10.1016/0022-1759(93)90129-u. J Immunol Methods. 1993. PMID: 8354894 Clinical Trial.

10

A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas--an Eastern Cooperative Oncology Group Study (E2392).

Hellman R, Neuberg DS, Wagner H, Grunnet M, Robins HI, Karp D, Flynn P, Adams G. Hellman R, et al. J Neurooncol. 1998 Mar;37(1):55-62. doi: 10.1023/a:1005867520788. J Neurooncol. 1998. PMID: 9525838 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year